Veterinary Medicine Information website

Dexacortin 2 mg/mL ml solution for injection for cattle, pigs, dogs and cats

Not authorised
  • Dexamethasone sodium phosphate
  • Dexamethasone sodium phosphate
Download as PDF

Product identification

Medicine name:
Dexacortin 2 mg/mL ml solution for injection for cattle, pigs, dogs and cats
Active substance:
  • Dexamethasone sodium phosphate
  • Dexamethasone sodium phosphate
Target species:
  • Cattle
  • Pig
  • Cattle
  • Pig
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Dexamethasone sodium phosphate
    2.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Dexamethasone sodium phosphate
    2.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        72
        hour
    • Pig
      • Meat and offal
        2
        day
  • Intravenous use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        72
        hour
    • Pig
      • Meat and offal
        2
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02AB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Slovenia
Package description:
  • Clear glass type I vials, closed with a bromobutylrubber stopper and sealed with an aluminium cap. One vial of 100 ml in a carton box.
  • Clear glass type I vials, closed with a bromobutylrubber stopper and sealed with an aluminium cap. One vial of 50 ml in a carton box.
  • Clear glass type I vials, closed with a bromobutylrubber stopper and sealed with an aluminium cap. One vial of 20 ml in a carton box.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International GmbH
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • DC/V/0086/001
Date of authorisation status change:
Reference member state:
  • Portugal
Procedure number:
  • PT/V/0136/001

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 23/01/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 23/01/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 23/01/2025
Download

Combined File of all Documents

English (PDF)
Published on: 1/09/2025
Download